Text
1. Of the instant lawsuit, the Plaintiff’s primary claim is dismissed.
2. The plaintiff's conjunctive claim is dismissed.
3...
Reasons
(b) In the preparation of a research plan for the name of the D subject, the name of the subject shall not exceed 110 million won per year, and the final goal of the support within 5 (23) years, for a total of 5 (23) years, for specific research tasks, the scale and period of technical assistance related to the relevant
B. At least 1 IND approval phase 1 above the final objective of bortus development and phase-by-level 2: Braculculous leading substance discovery phase-2: research to find out the effectiveness of serious animals subject to guidance, and non-clinical trial standards (GLP), and research to find out the source of immunity and to find the effect of the development of immunogens, including borringis, canis, and Bruis; 3rd research institute or research institute to which the research institute belongs is entitled, and 1) research institute or research institute to which the research institute or research institute belongs, including research findings of non-permanent trials (including GLP model) to determine whether the research institute or research institute is entitled to subsidization for at least 3 years; 1) research institute or research institute to which the research institute or research institute belongs, including research institute or research institute to which the research institute or research institute is entitled, and 3) research institute or research institute to which the research institute or research institute is entitled, and 1) research institute or research institute to which the research institute belongs.